Violeta
Senior Member
- Messages
- 2,998
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118948/
June, 2015
Katherine Bao and R. Lee Reinhardt
Interluekin-4 (IL-4) and IL-13 are two cytokines central to type-2 inflammation, and represent targetable candidates for the amelioration of allergic disease . IL-4 and IL-13 are required to drive most of the key hallmarks associated with type-2 inflammation including immunoglobulin E (IgE) production, smooth muscle contractility, mucus production, and innate cell recruitment to sites of inflammation.
June, 2015
Katherine Bao and R. Lee Reinhardt
Interluekin-4 (IL-4) and IL-13 are two cytokines central to type-2 inflammation, and represent targetable candidates for the amelioration of allergic disease . IL-4 and IL-13 are required to drive most of the key hallmarks associated with type-2 inflammation including immunoglobulin E (IgE) production, smooth muscle contractility, mucus production, and innate cell recruitment to sites of inflammation.